Suchergebnisse - "Rojo, Ricardo"

PubPharm (64)

1

Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis : A Post Hoc Analysis of JADE MONO-2

enthalten in: American journal of clinical dermatology | 2024

von Yosipovitch, G. | Gooderham, M. | Ständer, S. | +15

2

Corrigendum to "Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus - A proposal from an expert panel" [Autoimmunity Reviews, Volume 22, Issue 12, December 2023, 103479

enthalten in: Autoimmunity reviews | 2024

von Rojo, R. | Calvo Alén, J. | Prada, �. | +6

ErratumFor: Autoimmun Rev. 2023 Dec;22(12):103479. - PMID 37967782

3

Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus - A proposal from an expert panel

enthalten in: Autoimmunity reviews | 2023

von Rojo, R. | Calvo Alén, J. | Prada, �. | +6

ErratumIn: Autoimmun Rev. 2024 Jan 17;23(2):103517. - PMID 38237216

4

Efficacy and safety of abrocitinib monotherapy in adolescents and adults : a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial

enthalten in: The Journal of dermatological treatment | 2023

von Flohr, C. | Cork, M. | Ardern-Jones, M. | +6

5

Laboratory and clinical practices in antinuclear antibody detection and related antigens : recommendations from a Spanish multicentre survey

enthalten in: Immunologic research | 2023

von Martinez-Martinez, L. | Irure-Ventura, J. | Jurado, A. | +50

6

Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2

enthalten in: American journal of clinical dermatology | 2023

von Yosipovitch, G. | Gooderham, M. | Ständer, S. | +15

7

Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey

enthalten in: Immunologic research | 2023

von Martinez-Martinez, L. | Irure-Ventura, J. | Jurado, A. | +8

8

Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms : a plain language summary

enthalten in: Immunotherapy | 2023

von Reich, K. | Thyssen, J. | Blauvelt, A. | +13

9

Abrocitinib monotherapy in Investigator's Global Assessment nonresponders : improvement in signs and symptoms of atopic dermatitis and quality of life

enthalten in: The Journal of dermatological treatment | 2022

von Blauvelt, A. | Boguniewicz, M. | Brunner, P. | +6

10

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis : a randomised, double-blind, multicentre phase 3 trial

enthalten in: Lancet (London, England) | 2022

von Reich, K. | Thyssen, J. | Blauvelt, A. | +13

CommentIn: Lancet. 2022 Jul 23;400(10348):252-253. - PMID 35871800

1
2
3
4
5
6
7
Nächster »
[7]